Observational studyDrug design, development and therapy2016

Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.

Fabio Guerriero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.